Epofit (4000 iu) Injection Side Effects and usage

Epofit (4000 iu) - Erythropoietin (Recombinant Human Erythropoietin)- Injection is manufactured by Intas Pharmaceuticals Ltd. and the main constituent generic drug is Erythropoietin (Recombinant Human Erythropoietin)- 4000 iu.

Epofit (4000 iu) Injection Medicine Details

Side Effects

Hypertension, myalgia, arthralgia, flu like syndrome, rashes and urticaria.
Hypertensive crisis with encephalopathy-like symptoms e.
g.
headache, confusion, generalised seizures.
Thrombosis.
Arrhythmia, cardiac arrest, conjustive heart failure and precipitation of myocardial infarction.

Indications

Increase yield of autologous blood.
Anaemia of chronic renal failure.
Anaemia in zidovudine-treated HIV infected patients.
Anaemia related to non-myeloid malignant disease chemotherapy.

Contra Indications

Uncontrolled hypertension, hypersensitivity to mammalian cell products and human albumin.

Caution

Chronic renal failure, ischaemic heart diseases, hypertension, pregnancy, seizures, liver dysfunction, lactation.

Cost

The cost of the drug per 1 Vial is Rs.785 in India as of date.

Formulation

Epofit (4000 iu) Injection mainly contains the generic formulation called as Erythropoietin (Recombinant Human Erythropoietin)- 4000 iu.

Medicine Name: Epofit (4000 iu) Injection
Manufacturer: Intas Pharmaceuticals Ltd.
Generic Molecule: Erythropoietin (Recombinant Human Erythropoietin)

Epofit (4000 iu) Injection Similar Medicines List:

Epomine 2000 Iu Injection
Epomine 4000 Iu Injection
Eporise 2000 Iu Injection
Eporise 4000 Iu Injection
Eposed 100 Mg Injection